Please try another search
Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and cell therapies for the treatment of cancer, inflammatory conditions, and other diseases. The company develops NX-2127, an orally bioavailable Bruton’s tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies; NX-5948, an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; and NX-1607, an orally bioavailable Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor for immuno-oncology indications. It is also developing NX-0479/GS-6791, a IRAK4 degrader for the treatment of rheumatoid arthritis and other inflammatory diseases. The company has a strategic collaboration agreement with Gilead Sciences, Inc., Sanofi S.A., and Seagen Inc. co-development and co-commercialization for multiple drug candidates. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. Nurix Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Francisco, California.
Name | Age | Since | Title |
---|---|---|---|
Robert Tjian | 72 | 2016 | Chairman of Scientific Advisory Board |
David Lacey | 69 | 2016 | Independent Chairman |
Arthur T. Sands | 59 | 2014 | CEO, President & Director |
Julia Paige Gregory | 69 | 2019 | Independent Director |
John Kuriyan | - | - | Founder & Member of Scientific Advisory Board |
Lori Anne Kunkel | 64 | 2019 | Independent Director |
Judith A. Reinsdorf | 58 | 2021 | Independent Director |
Paul M. Silva | 56 | 2021 | Independent Director |
Arthur Weiss | - | - | Founder & Member of Scientific Advisory Board |
Michael Rapé | - | - | Founder & Member of Scientific Advisory Board |
Ronald Levy | - | 2023 | Member of Medical Advisory Board |
Roy D. Baynes | 68 | - | Member of Medical Advisory Board |
Edward C. Saltzman | 69 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review